SCHEMBL5218164

SCHEMBL5218164

CC(C)(C)N(C(=O)O)[C@@H](Cc1ccccc1)[C@H](O)CN[C@@H]1CCc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 4/20 0.44
BACE1 P56817 4/20 0.44
BACE2 Q9Y5Z0 3/20 0.44
MAOA P21397 3/20 0.41
MAOB P27338 3/20 0.41
EPHX2 P34913 2/20 0.41
BCHE P06276 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
ACHE P22303 1/20 0.40
ADRA1A P35348 1/20 0.40
HTR6 P50406 1/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
HTT P42858 2/20 0.40
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
SCN9A Q15858 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5218168 1.00 CTSD (0.44) CTSDBACE1BACE2MAOAMAOB
SCHEMBL5224081 0.87 BACE1 (0.48) CTSDBACE1BACE2MAOAMAOB
SCHEMBL5224073 0.87 BACE1 (0.48) CTSDBACE1BACE2MAOAMAOB
SCHEMBL5220607 0.81 VIPR2 (0.43) MMP1MMP2MMP9MMP8
SCHEMBL5220613 0.81 VIPR2 (0.43) MMP1MMP2MMP9MMP8
SCHEMBL5225206 0.81 VIPR2 (0.43) MMP1MMP2MMP9MMP8
SCHEMBL5225215 0.81 VIPR2 (0.43) MMP1MMP2MMP9MMP8
SCHEMBL5223477 0.79 BACE1 (0.44) CTSDBACE1BACE2
SCHEMBL4693111 0.79 BACE1 (0.41) CTSDBACE1BACE2
SCHEMBL5223476 0.79 BACE1 (0.44) CTSDBACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed